Genentech, a member of the Roche Group, today announced five-year follow-up data from the pivotal Phase III POLARIX study. The study evaluated Polivy® (polatuzumab vedotin-piiq) in combination with Rituxan® (rituximab),…
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) and the Institute for Follicular Lymphoma Innovation (IFLI) have entered into a strategic partnership to investigate the potential of IPH6501, Innate’s anti-CD20…
UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company focused on developing innovative treatments for urothelial and specialty cancers, has announced the presentation of the Phase 3 ENVISION trial’s efficacy and…
BostonGene, a leader in AI-driven molecular and immune profiling solutions, has announced that 10 of its abstracts have been selected for poster presentations, and two will be featured for online…
Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology, has announced the launch of the SHORTEN-ctDNA clinical trial at Columbia University. The study aims to assess the…
Presidio Medical, Inc., a clinical-stage company focused on developing a groundbreaking neuromodulation platform, is excited to announce the appointment of Richard J. Buchholz to its Board of Directors. Rick currently…
Hyperfine, Inc. (Nasdaq: HYPR), a leader in health technology, showcased data at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, highlighting the growing use of AI-powered…
ICON plc (NASDAQ: ICLR), a global leader in clinical research powered by healthcare intelligence, today revealed the results of a recent global survey involving 101 biotech and pharma professionals from…
Flatiron Health today announced its participation in the upcoming San Antonio Breast Cancer Symposium (SABCS), with four accepted abstracts for poster presentation. Additionally, the company will sponsor a session titled…
CVS Health Corporation (NYSE: CVS) has announced the commencement of cash tender offers for certain outstanding senior notes. These tender offers are being made for two categories of notes: the…
Vista, a leader in intelligent MRI acquisition software, has announced two-year clinical results demonstrating that Vista Cardiac enhances workflow efficiency, delivers high-quality and consistent imaging, and helps scale cardiac MRI…
Jack Nathan Medical Corp. (TSXV: “JNH”; OTCQB: “JNHMF”) has successfully completed the sale of its Canadian business to WELL Health Technologies Corp. (WELL), as part of a strategic shift in…